Biotech Breakouts & the GLP-1 Arms Race: The Drugs That Broke the Market (In a Good Way)
In this episode of Money Talks We Listen, Brian McAree and Richard Croft dive into two of the biggest forces shaping markets today: the biotech boom and rising energy prices. First, they unpack the GLP-1 revolution, exploring how breakthrough weight-loss drugs are transforming healthcare, creating trillion-dollar opportunities, and disrupting everything from food companies to insurance providers. Then they shift to oil’s march toward $100 per barrel, examining how geopolitics, inflation, consumer spending, and Federal Reserve policy are colliding in an increasingly fragile macroeconomic environment.

